Concept
Vaccination Status
Factors associated with persistent post-COVID-19 condition and functional limitation four years after SARS-CoV-2 infection | Scientific Reports / Baseline characteristics first follow-up survey (July–August 2021)
"At the time of infection, none of the participants had been vaccinated. At the time of the first survey (n = 992), 576 participants (58.1%) had received 1 vaccine dose, 268 (27.0%) 2 doses, and 148 (14.9%) remained unvaccinated."
Related Ideas
- Participant ProfileFactors associated with persistent post-COVID-19 condition and functional limitation four years after SARS-CoV-2 infection | Scientific Reports · Baseline characteristics second follow-up survey (March–September 2024)
- Repeated AssessmentFactors associated with persistent post-COVID-19 condition and functional limitation four years after SARS-CoV-2 infection | Scientific Reports · Follow-up survey (phase II)
- Questionnaire DataFactors associated with persistent post-COVID-19 condition and functional limitation four years after SARS-CoV-2 infection | Scientific Reports · Initial survey (phase I)
- Cohort DemographicsFactors associated with persistent post-COVID-19 condition and functional limitation four years after SARS-CoV-2 infection | Scientific Reports · Baseline characteristics first follow-up survey (July–August 2021)
- Concomitant DisordersFactors associated with persistent post-COVID-19 condition and functional limitation four years after SARS-CoV-2 infection | Scientific Reports · Baseline characteristics second follow-up survey (March–September 2024)
- Follow-up CohortFactors associated with persistent post-COVID-19 condition and functional limitation four years after SARS-CoV-2 infection | Scientific Reports · Baseline characteristics second follow-up survey (March–September 2024)
- Survey ProceduresFactors associated with persistent post-COVID-19 condition and functional limitation four years after SARS-CoV-2 infection | Scientific Reports · Initial survey (phase I)
- Survey TimingFactors associated with persistent post-COVID-19 condition and functional limitation four years after SARS-CoV-2 infection | Scientific Reports · Follow-up survey (phase II)